• Nov 16, 2017

    Opioid-related drug overdoses killed more than 33,000 Americans in 2015, according to the Centers for Disease Control and Prevention. Health publication STAT predicts opioids could cause 500,000 more deaths over the next 10 years. Making matters worse, patients often struggle to access and pay for opioid use disorder (OUD) treatment. A hub services provider like […]

    Read more
  • Providers
    Telehealth: Increasing Patient Access & Adherence

    Nov 9, 2017

    Health care providers are under increasing pressure to ensure therapies are necessary, evidence-based, and cost-effective. Telehealth has emerged to make value-based care more convenient and efficient. Using available information and technologies, providers can deliver care and education remotely, saving cost and easing patient adherence to therapy. Remote Patient Monitoring Home telehealth, also called remote patient […]

  • Pharma
    Pharmaceutical Manufacturing Predictions for 2018

    Nov 2, 2017

    Health care market trends have a direct impact on pharmaceutical manufacturers’ stakeholder interaction and value-based care agreements. Knowing those trends and planning around them will be key to pharma’s success. Industry analysts predict these three trends will dominate manufacturing in 2018: 1. Stronger Focus on Specialty Drugs & Rare Diseases Specialty drugs will account for […]

  • Providers
    Improving Patient Engagement Through Technology

    Oct 19, 2017

    Health care executives and clinicians discussed patient engagement technology in a recent New England Journal of Medicine survey. Respondents emphasized the advantages of predictive analytics—techniques for data-mining, statistical modeling, machine-learning, and artificial intelligence used to create more effective treatment plans. More than 50 percent said one of the top three benefits of patient engagement tools […]

  • Pharma
    Driving Progress in the Biosimilar Marketplace

    Oct 12, 2017

    In 2010, the Biologics Price Competition and Innovation Act (BPCIA) established an abbreviated approval pathway for “follow-on” biologics or biosimilar products. Since then, the market for biosimilars has been mired in uncertainty. The BPCIA contains language known as the “patent dance,” which has tied up the release of several biosimilar drugs. The patent dance instructs […]

  • Providers
    Human Touch: Maximizing the Effectiveness of Medical Devices

    Oct 5, 2017

    Remote patient monitoring uses mobile medical devices to collect and transmit patient data to health care providers in real time—without disrupting patients’ lives. For the best results, patients must understand how these devices work and how to use them. Unfortunately, even patients who learn every function of a new smartphone or flat-screen TV might not […]